Penumbra (PEN) Current Deferred Tax Assets (2014 - 2015)

Penumbra (PEN) posted quarterly Current Deferred Tax Assets of $7.3 million for Q3 2015, up 16.77% quarter-over-quarter from $6.3 million in Q4 2014.

Penumbra (PEN) Current Deferred Tax Assets (2014 - 2015) Analysis & Trends

Penumbra (PEN) has reported Current Deferred Tax Assets for 2 consecutive years, with $7.3 million the latest figure, recorded in Q3 2015.

In Q3 2015, Current Deferred Tax Assets changed N/A year-over-year to $7.3 million; the TTM figure through Sep 2015 stood at $7.3 million (changed N/A YoY), while the FY2014 annual figure was $6.3 million, changed N/A from the prior year.
Current Deferred Tax Assets rose to $7.3 million in Q3 2015 per PEN's latest filing, from $6.3 million in the prior quarter.
Across five years, Current Deferred Tax Assets topped out at $7.3 million in Q3 2015 and bottomed at $6.3 million in Q4 2014.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	199.49 Bn	193.88 Bn	7.27 Bn
2	Stryker	127.80 Bn	124.32 Bn	4.50 Bn
3	Medtronic	118.98 Bn	109.76 Bn	6.41 Bn
4	Boston Scientific	73.58 Bn	73.04 Bn	3.85 Bn
5	Edwards Lifesciences	51.93 Bn	47.68 Bn	1.35 Bn
6	Dexcom	34.34 Bn	32.39 Bn	830.00 Mn
7	GE HealthCare Technologies	33.76 Bn	31.66 Bn	2.18 Bn
8	Koninklijke Philips	26.37 Bn	23.05 Bn	4.55 Bn
9	Steris	23.07 Bn	22.59 Bn	684.20 Mn
10	Penumbra	12.79 Bn	12.13 Bn	264.94 Mn

Download Data